N-(2-(3-Bromophenyl)propan-2-yl)-2-chloroacetamide

Catalog No.: 
ACCHDG580
CAS No.: 
861840-21-3
Molecular Formula: 
C11H13BrClNO
Molecular Weight: 
290.59
N-(2-(3-Bromophenyl)propan-2-yl)-2-chloroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$558.00InquiryInquiry
100mg95%$872.00InquiryInquiry
250mg95%$2136.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-(3-Bromophenyl)propan-2-yl)-2-chloroacetamide
IUPAC NameN-(2-(3-bromophenyl)propan-2-yl)-2-chloroacetamide
Molecular FormulaC11H13BrClNO
Molecular Weight290.59
SMILESO=C(NC(C)(C1=CC=CC(Br)=C1)C)CCl
InChI KeyOJRDRYIRUGOQNL-UHFFFAOYSA-N
SynonymN-(2-(3-bromophenyl)propan-2-yl)-2-chloroacetamide;Acetamide, N-[1-(3-bromophenyl)-1-methylethyl]-2-chloro-
CAS No.861840-21-3

Synthetic Route by SureRoute

1. ACCHDG580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7In Stock
  2. Plus
  3. ACAOGZ685 route compound structure diagram
    ACAOGZ68530951-66-7In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCHDG580 route product structure diagram
    ACCHDG580861840-21-3
Inquiry

2. ACCHDG580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMNOT504 route compound structure diagram
    ACMNOT504676135-18-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHDG580 route product structure diagram
    ACCHDG580861840-21-3
Inquiry

3. ACCHDG580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMNOT504 route compound structure diagram
    ACMNOT504676135-18-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHDG580 route product structure diagram
    ACCHDG580861840-21-3
Inquiry

Comments (0)